PET/CT中SUV值与鼻咽癌临床分期的相关性研究

姚霞; 张晶晶; 韩玲; 庞然

doi:10.13201/j.issn.1001-1781.2017.06.013

PET/CT中SUV值与鼻咽癌临床分期的相关性研究

- 三峡大学附属宜昌市第二人民医院肿瘤医院肿瘤放化疗科(湖北宜昌, 443000)

详细信息

通讯作者: 姚霞, E-mail:kj34z8@163.com

中图分类号: R739.63

收稿日期: 2016-10-27

The ralationship between SUV values in PET/CT and clinical staging of nasopharyngeal carcinoma

- Department of Oncology, the Second People's Hospital of Yichang, Yichang, 443000, China

More Information

Corresponding author: YAO Xia, E-mail: kj34z8@163.com

Received Date: 27 October 2016

摘要

摘要: 目的: 研究鼻咽癌患者PET/CT中的鼻咽原发灶SUVmax(SUVmax-T)、转移淋巴结SUVmax(SUVmax-N)和鼻咽原发灶SUVmax与转移淋巴结SUVmax中取较大值(SUVmax值)与分期之间的临床意义。方法: 收集54例初治鼻咽癌患者治疗前的临床资料及PET/CT中的SUVmax值,使用Spearman相关性分析比较PET/CT的SUVmax-T、SUVmax-N和SUVmax值与临床分期之间的相关性。结果: SUVmax-T与T分期、临床分期之间差异有统计学意义(P<0.05);SUVmax-N与N分期、临床分期之间差异有统计学意义(P<0.01);SUVmax与T分期、N分期、临床分期之间差异有统计学意义(P<0.01);SUVmax与病理类型之间差异无统计学意义(P>0.05)。结论: PET/CT中SUVmax值与鼻咽癌临床分期有关。
- 鼻咽肿瘤 /
- PET/CT /
- 临床分期 /
- SUVmax
Abstract: Objective: The purpose of this study was to research the relationship between SUVmax-T, SUVmax-N and SUVmax value in the PET/CT and clinical stage in patients of nasopharyngeal carcinoma(NPC).Method: Collect the clinical data and SUX values of Fifty-four patients.The statistical analyses were performed by SPSS21.0 statistical software for Windows and the Pearson correlation analysis was used for data analysis.Result: SUVmax-T was significantly associated with T stage and clinical stage(P<0.05);SUVmax-N was significantly associated with N stage and clinical stage(P<0.01);SUVmax was significantly associated with T stage, N stage and clinical stage(P<0.01); there was no statistically significant difference betweeen SUVmax and pathology(P>0.05).Conclusion: The SUV values in PET/CT were associated with clinical stage of nasopharyngeal carcinioma(NPC).
- nasopharyngeal neoplasms /
- PET/CT /
- clinical stage /
- SUVmax

HTML全文

参考文献(14)

[1]	CAO S M, SIMONS M J, QIAN C N.The prevalence and prevention of nasopharyngeal carcinoma in China[J].Chin J Cancer, 2011, 30:114-119.
[2]	王瑞芝, 樊锐太.肿瘤放射治疗学[M].北京:人民卫生出版社, 2009:
[3]	WEI J, PEI S, ZHU X.Comparison of (18) F-FDGPET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma:a metaanalysis[J].Oral Oncol, 2015, 52:11-17.
[4]	VELLAYAPPAN B A, SOON Y Y, EARNEST A, et al.Accuracy of (18) F-flurodeoxyglucose-positron emission tomography/computed tomography in the staging of newly diagnosed nasopharyngeal carcinoma:a systematic review and meta-analysis[J].Radiol Oncol, 2014, 48:331-338.
[5]	XU G Z, GUAN D J, HE Z Y. (18) FDG-PET/CTfor detecting distant metastases and second primary cancers in patients with head andneck cancer.A metaanalysis[J].Oral Oncol, 2011, 47:560-565.
[6]	CHANG K P, CHANG Y T, WU C C, et al.Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival[J].Head Neck, 2011, 33:886-897.
[7]	SU M, ZHAO L, WEI H, et al.18F-fluorodeoxyglucose positron emission tomography for predicting tumor response toradiochemotherapy in nasopharyngeal carcinoma[J].Strahlenther Onkol, 2015, 191:642-648.
[8]	SHI Q, YANG Z, ZHANG Y, et al.Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma[J].PLoS One, 2014, 9:e103153-e103153.
[9]	XIAO W, XU A, HAN F, et al.Positron emission tomography-computed tomography before treatment is highly prognostic of distantmetastasis in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy treatment:aprospective study with longterm follow-up[J].Oral Oncol, 2015, 51:363-369.
[10]	ALLAL A S, SLOSMAN D O, KEBDANI T, et al.Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose[J].Int J Radiat Oncol Biol Phys, 2004, 59:1295-1300.
[11]	SEOL Y M, KWON B R, SONG M K, et al.Measurement of tumor volume by PET to evaluate progno sis in patients with head and neck cancer treatedby chemo-radiation therapy[J].Acta Oncol, 2010, 49:201-208.
[12]	CHAN S C, CHANG T C, WANG H M, et al.Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma:the role of standardized uptake value[J].Oral Oncol, 2008, 45:52-58.
[13]	MA B B, KING A, LO Y M, et al.Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolicactivity in advanced nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys, 2006, 66:714-720.
[14]	WANG W Y, TWU C W, LIN W Y, et al.Plasma Epstein-Barr virus DNA screening followed by 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma[J].Cancer, 2011, 117:4452-4459.